{"transactions":[{"id":2313830,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2022-03-30T21:16:03.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":186430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023."}],"balance_after":186430,"derivative":{"exercise_price":0.38,"expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":186430},"source":{"system":"sec-edgar","filing":"0001209191-22-021625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919122021625/doc4.xml","form_type":"4"}},{"id":2753772,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2021-04-07T20:11:15.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2031-04-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-025850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919121025850/doc4.xml","form_type":"4"}},{"id":2906852,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-14T21:18:49.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":13696,"price":1.1,"value":15065.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1580,"source":{"system":"sec-edgar","filing":"0001209191-21-003597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919121003597/doc4.xml","form_type":"4"}},{"id":2906851,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-14T21:18:49.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":6304,"price":1.05,"value":6619.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan."}],"balance_after":15276,"source":{"system":"sec-edgar","filing":"0001209191-21-003597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919121003597/doc4.xml","form_type":"4"}},{"id":2911729,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-09T00:11:44.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":8731,"price":0.94,"value":8207.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units."}],"balance_after":21580,"source":{"system":"sec-edgar","filing":"0001209191-21-002828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919121002828/doc4.xml","form_type":"4"}},{"id":2914526,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-01-07T00:15:07.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":11269,"price":0.94,"value":10592.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units."}],"balance_after":30311,"source":{"system":"sec-edgar","filing":"0001209191-21-002371","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919121002371/doc4.xml","form_type":"4"}},{"id":2935764,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-12-21T12:00:09.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":25000,"price":0.73,"value":18250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.75, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested restricted stock units."}],"balance_after":41580,"source":{"system":"sec-edgar","filing":"0001209191-20-064584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919120064584/doc4.xml","form_type":"4"}},{"id":2979329,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-11-16T21:01:43.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":10000,"price":0.81,"value":8100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.83, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested restricted stock units."}],"balance_after":66580,"source":{"system":"sec-edgar","filing":"0001209191-20-058450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919120058450/doc4.xml","form_type":"4"}},{"id":3012383,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-10-05T11:22:40.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":10000,"price":0.72,"value":7200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.72 to $0.74, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes unvested restricted stock units."}],"balance_after":76580,"source":{"system":"sec-edgar","filing":"0001209191-20-053429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919120053429/doc4.xml","form_type":"4"}},{"id":3177603,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T20:40:57.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":86580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted in lieu of a portion of the Reporting Person's cash salary. Subject to continued employment, the restricted stock units vest each day, pro rata based on the number of days between the grant date and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of\nthe Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":86580,"source":{"system":"sec-edgar","filing":"0001209191-20-024214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919120024214/doc4.xml","form_type":"4"}},{"id":3299774,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2020-01-28T22:03:20.000Z","date":"2020-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning January 25, 2021."}],"balance_after":20000,"derivative":{"exercise_price":1.71,"expiration_date":"2030-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-005187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919120005187/doc4.xml","form_type":"4"}},{"id":3344787,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-12-11T22:50:33.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":42859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date."}],"balance_after":42859,"derivative":{"exercise_price":0.9,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":42859},"source":{"system":"sec-edgar","filing":"0001209191-19-060088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919119060088/doc4.xml","form_type":"4"}},{"id":3507116,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":128621,"kind":"person","name":"Maloberti Renaud Bertrand","position":1,"cik":"0001744025","reported_name":"Maloberti Renaud Bertrand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options","published_at":"2019-05-30T23:33:13.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options become exercisable in three equal annual installments beginning on May 28, 2020."}],"balance_after":35000,"derivative":{"exercise_price":1.04,"expiration_date":"2029-05-28","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-033525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1681682/000120919119033525/doc4.xml","form_type":"4"}}]}